Skip to main content

Advertisement

Table 2 Immunophenotyping of leucocytes by flow cytometry

From: Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency

Immunophenotyping of leucocytes (x103cells/mm3)
Age at diagnosis Y: years/m: months Lymphocytes CD45+ CD3+ CD3+ CD4+ CD3+ CD8+ CD19+ HLA DR
1 10 y 2.9 (1.90–3.70) 2.6 (1.20–2.60) 0.6 (0.65–1.50) 1.9 (0.37–1.10) 0.2 (0.27–0.86) 0
2 2 y 6 m 4.6 (2.30–5.40) 2.4 (1.40–3.70) 0.5 (0.70–2.20) 1.5 (0.49–1.30) 1.2 (0.39–1.40) 0
3 4 y 6.2 (2.30–5.40) 4.8 (1.40–3.70) 0.3 (0.70–2.20) 2.9 (0.49–1.30) 0.2 (0.39–1.40) 0
4 2 m 3.3 (3.40–7.60) 1.6 (2.50–5.50) 0.4 (1.60–4.00) 1.2 (0.56–1.70) 0.7 (0.30–2.00) 0
5 1 y 10 m 1.2 (3.60–8.90) 0.3 (2.10–6.20) 0.2 (1.30–3.40) 0.1 (0.62–2.00) 0.4 (0.72–2.60) 0
6 4 y 1.5 (2.30–5.40) 0.7 (1.40–3.70) 0.3 (0.70–2.20) 0.3 (0.49–1.30) 0.3 (0.39–1.40) 0
7 2 y 3 m 4 (2.30–5.40) 2.5 (1.40–3.70) 1.4 (0.70–2.20) 0.6 (0.49–1.30) 1.1 (0.39–1.40) 0
8 4 y 3.7 (2.30–5.40) 2.3 (1.40–3.70) 3.3 (0.70–2.20) 1.1 (0.49–1.30) 0.4 (0.39–1.40) 0
9 2 y 1.2 (2.30–5.40) 0.8 (1.40–3.70) 0.2 (0.70–2.20) 0.5 (0.49–1.30) 0.07 (0.39–1.40) 0
10 6 y 3.2 (1.90–3.70) 2.4 (1.20–2.60) 0.3 (0.65–1.50) 1.5 (0.37–1.10) 0.4 (0.27–0.86) 0
11 4 y 3.5 (2.30–5.40) 1.9 (1.40–3.70) 0.15 (0.70–2.20) 1 (0.49–1.30) 0.18 (0.39–1.40) 0
  1. (Normal values for age are given between brackets)[20].